Methylation of p16INK4a promoters occurs in vivo in histologically normal human mammary epithelia

Cancer Research

Volumn 63, Issue 7, 2003, Pages 1596-1601

  Holst, Charles R ^a   Nuovo, Gerard J ^b   Esteller, Manel ^c,d   Chew, Karen ^a   Baylin, Stephen B ^c   Herman, James G ^c   Tlsty, Thea D ^a,e  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b THE OHIO STATE UNIVERSITY WEXNER MEDICAL CENTER   (United States)

^c JOHNS HOPKINS UNIVERSITY   (United States)

^d Centro Nacional de Investigaciones Oncológicas   (Spain)

^e UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN P16;

ADULT; AGED; ARTICLE; BREAST EPITHELIUM; CELL CULTURE; CELL PROLIFERATION; EPITHELIUM CELL; GENE SILENCING; HISTOLOGY; HUMAN; HUMAN TISSUE; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN METHYLATION;

NASA DISCIPLINE RADIATION HEALTH; NON-NASA CENTER;

BREAST; CELLS, CULTURED; CYCLIN-DEPENDENT KINASE INHIBITOR P16; DNA METHYLATION; EPITHELIAL CELLS; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; PROMOTER REGIONS (GENETICS);

EID: 0037380886     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Romanov, S. R., Kozakiewicz, B. K., Holst, C. R., Stampfer, M. R., Haupt, L. M., and Tlsty, T. D. Normal human mammary epithelial cells spontaneously escape senescence and acquire genomic changes. Nature (Lond.), 409: 633-637, 2001.
2. Tlsty, T. D., Romanov, S. R., Kozakiewicz, B. K., Holst, C. R., Haupt, L. M., and Crawford, Y. G. Loss of chromosomal integrity in human mammary epithelial cells subsequent to escape from senescence. J. Mammary Gland Biol. Neoplasia, 6: 235-243, 2001.
3. Hammond, S. L., Ham, R. G., and Stampfer, M. R. Serum-free growth of human mammary epithelial cells: rapid clonal growth in defined medium and extended serial passage with pituitary extract. Proc. Natl. Acad. Sci. USA, 81: 5435-5439, 1984.
4. Brenner, A. J., Stampfer, M. R., and Aldaz, C. M. Increased p16 expression with first senescence arrest in human mammary epithelial cells and extended growth capacity with p16 inactivation. Oncogene, 17: 199-205, 1998.
5. Foster, S. A., Wong, D. J., Barrett, M. T., and Galloway, D. A. Inactivation of p16 in human mammary epithelial cells by CpG island methylation. Mol. Cell. Biol, 18: 1793-1801, 1998.
6. Huschtscha, L. I., Noble, J. R., Neumann, A. A., Moy, E. L., Barry, P., Melki, J. R., Clark, S. J., and Reddel, R. R. Loss of p16INK4 expression by methylation is associated with lifespan extension of human mammary epithelial cells. Cancer Res., 58: 3508-3512, 1998.
7. o growth arrest. Mol. Cell. Biol, 19: 5642-5651, 1999.
8. Shen, C. Y., Yu, J. C., Lo, Y. L., Kuo, C. H., Yue, C. T., Jou, Y. S., Huang, C. S., Lung, J. C., and Wu, C. W. Genome-wide search for loss of heterozygosity using laser capture microdissected tissue of breast carcinoma: an implication for mutator phenotype and breast cancer pathogenesis. Cancer Res., 60: 3884-3892, 2000.
9. Teixeira, M. R., Pandis, N., and Heim, S. Cytogenetic clues to breast carcinogenesis. Genes Chromosomes Cancer, 33: 1-16, 2002.
10. Herman, J. G., Graff, J. R., Myohanen, S., Nelkin, B. D., and Baylin, S. B. Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands. Proc. Natl. Acad. Sci. USA, 93: 9821-9826, 1996.
11. Nuovo, G. J., Plaia, T. W., Belinsky, S. A., Baylin, S. B., and Herman, J. G. In situ detection of the hypermethylation-induced inactivation of the p16 gene as an early event in oncogenesis. Proc. Natl. Acad. Sci. USA, 96: 12754-12759, 1999.
12. Luria, S. E., and Delbrück, M. Mutations of bacteria from virus sensitivity to virus resistance. Genetics, 28: 491-511, 1943.
13. Tlsty, T. D., Margolin, B. H., and Lum, K. Differences in the rates of gene amplification in nontumorigenic and tumorigenic cell lines as measured by Luria-Delbrück fluctuation analysis. Proc. Natl. Acad. Sci. USA, 86: 9441-9445, 1989.
14. Bondeson, L., Linell, F., and Ringberg, A. Breast reductions: what to do with all the tissue specimens? Histopathology, 9: 281-285, 1985.
15. Gonzalez-Zulueta, M., Bender, C. M., Yang, A. S., Nguyen, T., Beart, R. W., Van Tornout, J. M., and Jones, P. A. Methylation of the 5′ CpG island of the p16/CDKN2 tumor suppressor gene in normal and transformed human tissues correlates with gene silencing. Cancer Res., 55: 4531-4535, 1995.
16. Herman, J. G., Merlo, A., Mao, L., Lapidus, R. G., Issa, J. P., Davidson, N. E., Sidransky, D., and Baylin, S. B. Inactivation of the CDKN2/p16/MTS1 gene is frequently associated with aberrant DNA methylation in all common human cancers. Cancer Res., 55: 4525-4530, 1995.
17. Merlo, A., Herman, J. G., Mao, L., Lee, D. J., Gabrielson, E., Burger, P. C., Baylin, S. B., and Sidransky, D. 5′ CpG island methylation is associated with transcriptional silencing of the tumour suppressor p16/CDKN2/MTS1 in human cancers. Nat. Med., 1: 686-692, 1995.
18. Chin, L., Pomerantz, J., and DePinho, R. A. The INK4a/ARF tumor suppressor: one gene-two products-two pathways. Trends Biochem. Sci., 23: 291-296, 1998.
19. Sherr, C. J. Cancer cell cycles. Science (Wash. DC), 274: 1672-1677, 1996.
20. Cairns, P., Polascik, T. J., Eby, Y., Tokino, K., Califano, J., Merlo, A., Mao, L., Herath, J., Jenkins, R., Westra, W., et al. Frequency of homozygous deletion at p16/CDKN2 in primary human tumours. Nat. Genet., 11: 210-212, 1995.
21. Esteller, M., Fraga, M. F., Guo, M., Garcia-Foncillas, J., Hedenfalk, I., Godwin, A. K., Trojan, J., Vaurs-Barriere, C., Bignon, Y. J., Ramus, S., Benitez, J., Caldes, T., Akiyama, Y., Yuasa, Y., Launonen, V., Canal, M. J., Rodriguez, R., Capella, G., Peinado, M. A., Borg, A., Aaltonen, L. A., Ponder, B. A., Baylin, S. B., and Herman, J. G. DNA methylation patterns in hereditary human cancers mimic sporadic tumor-igenesis. Hum. Mol. Genet., 10: 3001-3007, 2001.
22. Nielsen, M., Thomsen, J. L., Primdahl, S., Dyreborg, U., and Andersen, J. A. Breast cancer and atypia among young and middle-aged women: a study of 110 medicolegal autopsies. Br. J. Cancer, 56: 814-819, 1987.
23. Alpers, C. E., and Wellings, S. R. The prevalence of carcinoma in situ in normal and cancer-associated breasts. Hum. Pathol., 16: 796-807, 1985.
24. Bartow, S. A., Pathak, D. R., Black, W. C., Key, C. R., and Teaf, S. R. Prevalence of benign, atypical, and malignant breast lesions in populations at different risk for breast cancer. A forensic autopsy study. Cancer (Phila.), 60: 2751-2760, 1987.
25. Bhathal, P. S., Brown, R. W., Lesueur, G. C., and Russell, I. S. Frequency of benign and malignant breast lesions in 207 consecutive autopsies in Australian women. Br. J. Cancer, 51: 271-278, 1985.
26. Welch, H. G., and Black, W. C. Using autopsy series to estimate the disease "reservoir" for ductal carcinoma in situ of the breast: how much more breast cancer can we find? Ann. Intern. Med., 127: 1023-1028, 1997.
27. Deng, G., Lu, Y., Zlotnikov, G., Thor, A. D., and Smith, H. S. Loss of heterozygosity in normal tissue adjacent to breast carcinomas. Science (Wash. DC), 274: 2057-2059, 1996.
28. Larson, P. S., de las Morenas, A., Cupples, L. A., Huang, K., and Rosenberg, C. L. Genetically abnormal clones in histologically normal breast tissue. Am. J. Pathol., 152: 1591-1598, 1998.
29. Kandel, R., Li, S. Q., Ozcelik, H., and Rohan, T. p53 protein accumulation and mutations in normal and benign breast tissue. Int. J. Cancer, 87: 73-78, 2000.